0000899243-18-031479.txt : 20181220
0000899243-18-031479.hdr.sgml : 20181220
20181220162230
ACCESSION NUMBER: 0000899243-18-031479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181218
FILED AS OF DATE: 20181220
DATE AS OF CHANGE: 20181220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KURIYEL RALF
CENTRAL INDEX KEY: 0001733143
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 181246449
MAIL ADDRESS:
STREET 1: 41 SEYON ST
STREET 2: BLDG 1, STE. 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-18
0
0000730272
REPLIGEN CORP
RGEN
0001733143
KURIYEL RALF
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Senior VP, R&D
Common Stock
2018-12-18
4
S
0
311
54.44
D
12294
D
Sale of 311 shares in the open market valued at a price of $54.44 per share on December 18,2018 to cover tax liability resulting from the release of restricted stock units.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2018-12-20